Dr. John Michael Tate, MD

Dr. Tate practices at CentraCare - Rice Memorial Hospital in Willmar, Minnesota, part of CentraCare Health System.

Dr. Tate's NPI, 1134141708, was assigned on July 24, 2006. Dr. Tate holds North Dakota license 8586.

Dr. Tate's primary practice is CentraCare - Rice Memorial Hospital, at 301 Becker Ave SW, Willmar, MN 56201 in Kandiyohi County. The practice phone is (320) 235-4543.

Dr. Tate's primary practice is CentraCare - Rice Memorial Hospital in Willmar, Minnesota, part of CentraCare Health System. Dr. Tate is also affiliated with CentraCare - St. Cloud Hospital. The medical group on file is Lake Region Healthcare. Dmand AI also links Dr. Tate to 3 more hospitals, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account. Dr. Tate's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tate practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Tate's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Tate's licenses on file in 2 states: North Dakota and Minnesota.

CMS data shows 361 Medicare services from Dr. Tate across 4 procedure codes in 2024, all of them office visits, for 121 Medicare patients. Medicare paid $22,930 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Tate in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tate's median patient age at 75, with 53% women.

In 2024, Dr. Tate wrote 942 Medicare Part D claims for 169 patients. 85% of them were for generic drugs. CMS names the drug for 602 of them, across 26 drugs with 11 or more claims each, at $760,491 in total drug cost. In 2023, CMS named 771 claims across 32 drugs.

Dr. Tate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tate as offering telehealth.

CMS Open Payments shows 6 general payments to Dr. Tate from 4 drug and device companies from 2018 to 2025. Education make up the largest share, 65% of the total. Pfizer Inc. paid the most, $52.